Gideon Obasanmi
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Granzyme B degrades extracellular matrix and promotes inflammation and choroidal neovascularization.
Granzyme B degrades extracellular matrix and promotes inflammation and choroidal neovascularization.
Journal: Angiogenesis
Published: September 25, 2023
Granzyme B Contributes to Choroidal Neovascularization and Age-Related Macular Degeneration Through Proteolysis of Thrombospondin-1.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: February 07, 2023
Antioxidant Phytochemicals as Potential Therapy for Diabetic Complications.
Journal: Antioxidants (Basel, Switzerland)
Published: October 30, 2022
Potential role of extracellular granzyme B in wet age-related macular degeneration and fuchs endothelial corneal dystrophy.
Journal: Frontiers in pharmacology
Published: June 28, 2022
Successful Proof-of-Concept for Topical Delivery of Novel Peptide ALM201 with Potential Usefulness for Treating Neovascular Eye Disorders.
Journal: Ophthalmology science
Published: October 01, 2021
Hyaloid Vasculature as a Major Source of STAT3+ (Signal Transducer and Activator of Transcription 3) Myeloid Cells for Pathogenic Retinal Neovascularization in Oxygen-Induced Retinopathy.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: October 29, 2020
Circulating Leukocyte Alterations and the Development/Progression of Diabetic Retinopathy in Type 1 Diabetic Patients - A Pilot Study.
Journal: Current eye research
Published: January 31, 2020
STAT3 activation in circulating myeloid-derived cells contributes to retinal microvascular dysfunction in diabetes.
Journal: Journal of neuroinflammation
Published: March 25, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026